Medicskin Holdings Limited (Medicskin) filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during the month.

The company’s authorised share capital stood at 1.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 10.00 million. Issued share capital was stable at 396.74 million ordinary shares, and Medicskin continued to hold no treasury shares.

Public float requirements were met, with at least 25% of issued shares in public hands, as stipulated by GEM Rule 17.37B.

Under the Share Option Scheme adopted on 27 September 2024, Medicskin retained the capacity to issue or transfer up to 39.67 million shares, representing approximately 10% of current issued share capital. No options were outstanding, granted, exercised, or cancelled during the month, and no funds were raised from option exercises.

The company reported no outstanding warrants, convertible securities, or other share-issuing arrangements, and there were no share repurchases or treasury-share transactions in March 2026.

The filing was authorised by Executive Director and Company Secretary Christine Sin on 1 April 2026. All required confirmations under GEM Rule 17.27C were provided, indicating compliance with listing and regulatory obligations.